Glycogen synthase kinase 3 beta (GSK3B) antibody lowers blood pressure in animals. PDF Print
MarketWire: DiaMedica (TSX VENTURE:DMA) today announces antihypertensive results with its lead monoclonal antibody DM-204. Consistent and significant blood pressure lowering results are observed with DM-204 in all animals and the lower blood pressure occurred for the duration of the study performed.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.